BackOrphazyme A/S Overview

Orphazyme A/S Current Assets

Orphazyme A/S's current assets is $17M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$16.53M
↑ 8.23% YoYΔ $1.26M vs prior year quarter

Peer trimmed avg / median

Loading

Orphazyme A/S Current Assets History

Loading

Orphazyme A/S vs. peers: Current Assets Comparison

Loading

Orphazyme A/S Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orphazyme A/S (ORPHA.CO) FAQ

The latest current assets for ORPHA.CO is $17M as of June 2026. That compares with $15M in the prior-year period — up 8.2% year over year. Investors often review this figure alongside Orphazyme A/S's historical trend and sector peers before judging valuation or financial health.

Over the past year, ORPHA.CO's current assets moved from $15M to $17M — a 8.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Orphazyme A/S's operating scale or balance-sheet position.

A current assets figure of $17M for ORPHA.CO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ORPHA.CO's current assets ($17M), review year-over-year change from $15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Orphazyme A/S's current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.